Clozapine improves dyskinesias in Parkinson disease: a double-blind, placebo-controlled study.
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003024:Clozapine / Q000627:therapeutic use*; D004311:Double-Blind Method; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D008875:Middle Aged; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D017366:Serotonin Receptor Agonists; D007980:Levodopa; D003024:Clozapine